Words in motion: Motor-language coupling in Parkinson’s disease

2014 ◽  
Vol 5 (2) ◽  
Author(s):  
Adolfo García ◽  
Agustín Ibáñez

AbstractA growing body of evidence indicates that neurodegenerative motor disorders involved high-order cognitive dysfunctions. Crucially, evidence obtained in multiple behavioral, neuroimaging, and electrophysiological studies points to selective impairments of action language -that is, processing of linguistic stimuli denoting motor actions, including idioms (e.g., cut a rug) and action verbs (e.g., clap). Action-verb deficits (with relative preservation of noun processing) have been repeatedly documented in Parkinson’s disease (PD). However, research on relevant biomarkers is still scant, and clinical implications of these findings have not yet been formally discussed. Relevant insights may be obtained through the assessment of motor-language coupling (i.e., the behavioral and neural integration of action-verb processing and ongoing motor actions). We propose that motorlanguage coupling deficits, as indexed by a cortical-subcortical network, may constitute an early neurocognitive marker of PD. Specifically, deficits in this domain at the prodromal stage may be detected through the actionsentence compatibility (ACE) paradigm, which induces a contextual coupling of ongoing motor actions and action-verb processing. Our translational proposal is supported and illustrated by recent studies demonstrating the sensitivity of the ACE technique as well as its potential to assist in differential diagnosis and interventionprogram design.

2013 ◽  
Vol 218 (6) ◽  
pp. 1355-1373 ◽  
Author(s):  
Juan Felipe Cardona ◽  
Oscar Gershanik ◽  
Carlos Gelormini-Lezama ◽  
Alexander Lee Houck ◽  
Sebastian Cardona ◽  
...  

2015 ◽  
Vol 137 (4) ◽  
pp. 2431-2432
Author(s):  
Emily Wang ◽  
Lee K. Walters ◽  
Leo A. Verhagen Metman

2016 ◽  
Vol 55 (4) ◽  
pp. 1429-1435 ◽  
Author(s):  
Sofía Abrevaya ◽  
Lucas Sedeño ◽  
Sol Fitipaldi ◽  
David Pineda ◽  
Francisco Lopera ◽  
...  

2016 ◽  
Vol 108 ◽  
pp. 114-115 ◽  
Author(s):  
Sofía Abrevalla ◽  
Lucas Sedeno ◽  
Sol Fitipaldi ◽  
Agustin Ibañez ◽  
Adolfo García-Cordero

2014 ◽  
Vol 8 (1) ◽  
pp. 3-13 ◽  
Author(s):  
Henrique Salmazo da Silva ◽  
Juliana Machado ◽  
André Cravo ◽  
Maria Alice de Mattos Pimenta Parente ◽  
Maria Teresa Carthery-Goulart

ABSTRACT The objective of the current review was to verify whether studies investigating lexical-semantic difficulties in patients with Parkinson's disease (PD) support the Embodied Cognition model. Under this framework, it is predicted that patients with PD will have more difficulties in the semantic processing of action concepts (action verbs) than of motionless objects. We also verified how and whether these studies are following current debates of Neuroscience, particularly the debate between the Lexical and the Embodied Cognition models. Recent neuroimaging studies on the neural basis of the semantics of verbs were presented, as well as others that focused on the neural processing of verbs in PD. We concluded that few studies suitably verified the Embodied Cognition theory in the context of PD, especially using neuroimaging techniques. These limitations show there is much to investigate on the semantic difficulties with action verbs in these patients, where it is particularly important to control for psycholinguistic variables and the inherent semantic characteristics of verbs in future studies.


2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
Veronica Ghiglieri ◽  
Vincenza Bagetta ◽  
Valentina Pendolino ◽  
Barbara Picconi ◽  
Paolo Calabresi

In Parkinson’s disease (PD), alteration of dopamine- (DA-) dependent striatal functions and pulsatile stimulation of DA receptors caused by the discontinuous administration of levodopa (L-DOPA) lead to a complex cascade of events affecting the postsynaptic striatal neurons that might account for the appearance of L-DOPA-induced dyskinesia (LID). Experimental models of LID have been widely used and extensively characterized in rodents and electrophysiological studies provided remarkable insights into the inner mechanisms underlying L-DOPA-induced corticostriatal plastic changes. Here we provide an overview of recent findings that represent a further step into the comprehension of mechanisms underlying maladaptive changes of basal ganglia functions in response to L-DOPA and associated to development of LID.


Cortex ◽  
2015 ◽  
Vol 69 ◽  
pp. 237-254 ◽  
Author(s):  
Yamile Bocanegra ◽  
Adolfo M. García ◽  
David Pineda ◽  
Omar Buriticá ◽  
Andrés Villegas ◽  
...  

2021 ◽  
pp. 1-10
Author(s):  
Keran Wang ◽  
Zhehui Luo ◽  
Chenxi Li ◽  
Xuemei Huang ◽  
Eric J. Shiroma ◽  
...  

Background: Literature shows an inverse association of circulating cholesterol level with the risk of Parkinson’s disease (PD); this finding has important ramifications, but its interpretation has been debated. Objective: To longitudinally examine how blood total cholesterol changes during the development of PD. Methods: In the Health, Aging and Body Composition study (n = 3,075, 73.6±2.9 years), blood total cholesterol was measured at clinic visit years 1, 2, 4, 6, 8, 10, and 11. We first examined baseline cholesterol in relation to PD risk, adjusting for potential confounders and competing risk of death. Then, by contrasting the observed with expected cholesterol levels, we examined the trajectory of changes in total cholesterol before and after disease diagnosis. Results: Compared to the lowest tertile of baseline total cholesterol, the cumulative incident ratio of PD and 95%confidence interval was 0.41 (0.20, 0.86) for the second tertile, and 0.69 (0.35, 1.35) for the third tertile. In the analysis that examined change of total cholesterol level before and after PD diagnosis, we found that its level began to decrease in the prodromal stage of PD and became statistically lower than the expected values∼4 years before disease diagnosis (observed-expected difference, –6.68 mg/dL (95%confidence interval: –13.14, –0.22)). The decreasing trend persisted thereafter; by year-6 post-diagnosis, the difference increased to –13.59 mg/dL (95%confidence interval: –22.12, –5.06), although the linear trend did not reach statistical significance (p = 0.10). Conclusion: Circulating total cholesterol began to decrease in the prodromal stage of PD, which may in part explain its reported inverse association with PD.


Cortex ◽  
2009 ◽  
Vol 45 (8) ◽  
pp. 960-971 ◽  
Author(s):  
Patrice Péran ◽  
Dominique Cardebat ◽  
Andrea Cherubini ◽  
Fabrizio Piras ◽  
Giacomo Luccichenti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document